Free shipping on all orders over $ 500

Tirbanibulin (KX2-391)

Cat. No. M2313

All AbMole products are for research use only, cannot be used for human consumption.

Tirbanibulin (KX2-391) Structure
Synonym:

KX-01

Size Price Availability Quantity
1mg USD 30  USD30 In stock
5mg USD 65  USD65 In stock
10mg USD 80  USD80 In stock
50mg USD 320  USD320 In stock
100mg USD 540  USD540 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tirbanibulin (KX2-391) is a synthetic, orally bioavailable small molecule and non-ATP competitive Src tyrosine kinase signaling inhibitor with an IC50 of average 72 nM. Tirbanibulin (KX2-391) has potential antineoplastic activity. Src kinase inhibitor KX2-391 specifically binds to the peptide substrate binding site of Src kinase. In addition, Tirbanibulin (KX2-391) also inhibits microtubule polymerization. Preclinical studies have suggested that KX2-391 is able to prevent the proliferation and metastasis of prostate cancer cell lines in mouse xenografts. 

Chemical Information
Molecular Weight 431.53
Formula C26H29N3O3
CAS Number 897016-82-9
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Anna H Dlott, et al. Tirbanibulin: Topical Treatment for Actinic Keratosis

[2] No authors listed. Am J Health Syst Pharm. Tirbanibulin

[3] Anthony Markham, et al. Tirbanibulin: First Approval

[4] Andrew Blauvelt, et al. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis

[5] No authors listed. Tirbanibulin

Related Src-bcr-Abl Products
Risvodetinib

Risvodetinib (IkT-148009) is an orally active, selective and brain-penetrant protein tyrosine kinase inhibitor, displaying excellent target efficacy against c-Abl1, c-Abl2/Arg with IC50 values of 33 nM, 14 nM, respectively.

SI-2 hydrochloride

SI-2 hydrochloride is a highly promising SRC-3 inhibitor (PPI) with acceptable oral availability, with IC50 values of 3-20 nM for breast cancer cell death.

KB SRC 4 

KB SRC 4 is a potent, and highly selective c-Src inhibitor, with a Ki of 44 nM and a Kd of 86 nM, and shows no inhibition on c-Abl up to 125 μM; KB SRC 4 has antitumor activity.

Hydroxymethyl dasatinib 

Hydroxymethyl dasatinib (M24), a benzylhydroxy metabolite of Dasatinib, exhibits an IC50 of 46.7nM in K562 CML cells.

Asciminib hydrochloride

Asciminib (ABL001) hydrochloride is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0.25 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tirbanibulin (KX2-391), KX-01 supplier, Src-bcr-Abl, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.